The lack or reduced expression of RUNX1 also affects the activity of MYB, MYC, and GATA3 oncogenes, which confirms the key role of RUNX1 in the pathogenesis of T-ALL (24). Here, RUNX1 is linked to acute lymphoblastic leukemia.